M-Xylene

M-Xylene

SCHEMBL8710882

Cc1cc(C)c2c(c1)C(=O)C(C)C2.Cc1cccc(C)c1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ACHE P22303 11/20 0.61
ALOX15 P16050 1/20 0.35
ALOX12 P18054 1/20 0.35
BRD4 O60885 1/20 0.35
CREBBP Q92793 1/20 0.35
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MAOA P21397 2/20 0.34
CYP19A1 P11511 1/20 0.34
MAOB P27338 1/20 0.34
ACLY P53396 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2047790 0.90 ACHE (0.58) ACHE
SCHEMBL5952914 0.78 ACHE (0.66) ACHEBRD4CREBBPKDM4EMAOA
SCHEMBL5952218 0.77 ACHE (0.64) ACHELMNACYP19A1MAOB
SCHEMBL5952851 0.77 ACHE (0.64) ACHEBRD4KDM4ELMNAHTT
SCHEMBL30666460 0.76 ACHE (1.00) ACHECREBBPMAOAMAOB
SCHEMBL6936179 0.76 ACHE (1.00) ACHECREBBPMAOAMAOB
SCHEMBL5951978 0.76 ACHE (0.50) ACHEALOX15MAOACYP19A1MAOB
SCHEMBL5951456 0.76 ACHE (0.63) ACHEBRD4CREBBPKDM4E
SCHEMBL5952610 0.75 ACHE (0.61) ACHEALOX15ALOX12BRD4CREBBP
SCHEMBL2481363 0.73 ACHE (0.50) ACHEMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0874860-A1 SUBSTITUTED INDENYL CONTAINING METAL COMPLEXES AND OLEFIN POLYMERIZATION PROCESS THE DOW CHEMICAL COMPANY (US) 1998-11-04 EP disclosed
WO-1997015583-A1 SUBSTITUTED INDENYL CONTAINING METAL COMPLEXES AND OLEFIN POLYMERIZATION PROCESS THE DOW CHEMICAL COMPANY (US) 1997-05-01 WO disclosed